| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62cf0ed63eaede808199e5d62a6db9ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63bcfb57003bfa6e84cb5aab09ff9ee3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bde37e8975f9d72f4b60c876939684d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff764213f9a6e9d9a6242656240b1471
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9835e79b3e02c1a10ee3b59e5cfca55a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-18 |
| filingDate |
2008-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf721abf0bfc74f1f7629044480eebdc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_185495431ebd83d06106f33dc3690133
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87419c84245f57616715a73aa93cdd6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dea2b90019ae5348fbd21f0685d89638 |
| publicationDate |
2008-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008098211-A1 |
| titleOfInvention |
Treatment of glaucoma and diabetic retinopathy with morinda citrifolia enhanced formulations |
| abstract |
The present invention relates to methods and formulations directed inhibiting carbonic anhydrase, fatty acid amide hydrolase and endothelin-converting enzymes comprising the administration of processed Monnda citrifolia based formulations. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109557309-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109557309-A |
| priorityDate |
2007-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |